Clinical Observation of Erlotnib in the Treatment of Non-small Cell Lung Cancer with Multimetastases in Elderly Patients

Clinical Observation of Erlotnib in the Treatment of Non-small Cell Lung Cancer with Multimetastases in Elderly Patients

Background and objective Erlotnib is the inhibitor of epidemic growth factor receptor and mainly used to treat non-small cell lung cancer (NSCLC). The aim of this study is to evaluate the antitumor efficacy and toxicity of erlotnib in the treatment of Chinese elderly NSCLC patients with multimetasta...

Full description

Bibliographic Details
Main Authors:	Binying ZOU, Yanwei MA, You YU, Lina XING, Feng ZHANG
Format:	Article
Language:	zho
Published:	Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2009-12-01
Series:	Chinese Journal of Lung Cancer
Subjects:	Epidermal growth factor receptor Erlotnib Lung neoplasms The aged
Online Access:	http://www.lungca.org/index.php?journal=01&page=article&op=viewFile&path[]=10.3779%2Fj.issn.1009-3419.2009.12.04&path[]=1228

Similar Items

Erlotinib as the Second-line Treatment for NSCLC Patients of Stage IIIb/IV
by: Tian LI
Published: (2009-12-01)

Clinical Observation of EGFR-TKI as A First-line Therapy on Advanced Non-small Cell Lung Cancer
by: Jianjie LI, et al.
Published: (2012-05-01)

Epidermal Growth Factor Receptor Mutations and Radiotherapy  in Non-small Cell Lung Cancer
by: Xing ZHONG, et al.
Published: (2013-03-01)

Immunotherapy in Epidermal Growth Factor Receptor-mutant  Non-small Cell Lung Cancer
by: Xin WANG, et al.
Published: (2019-08-01)

Progress in Non-invasive Detection of EGFR Mutation in Non-small Cell Lung Cancer
by: Shiyang YUAN, et al.
Published: (2018-12-01)

EGFR Gene Mutation Statuses in Advanced Non-small Cell Lung Cancer Patients and Their Influence on Effect of Gefitinib
by: Wei ZHONG, et al.
Published: (2012-09-01)

Research Progress of Targeted Therapy for EGFR Gene in Non-small Cell Lung Cancer
by: Hui ZHANG, et al.
Published: (2017-01-01)

Epidermal growth factor receptor inhibitors in non-small cell lung cancer: current status and future perspectives
by: Mauro Zükin
Published: (2012-04-01)

Modified Restriction Enzyme-based Detection of EGFR Mutations in Lung Cancer
by: Fan YANG, et al.
Published: (2011-08-01)

Surgical Treatment and Prognosis for Patients with  Synchronous Multiple Primary Lung Adenocarcinomas
by: Yue PENG, et al.
Published: (2017-02-01)

Advanced Research on Non-small Cell Lung Cancer with De Novo T790M Mutation
by: Xin WANG, et al.
Published: (2019-05-01)

Four Cases of Interstitial Lung Disease Induced by Erlotinib  and A Review of the Literatures
by: Xiaoling WU, et al.
Published: (2012-08-01)

The Association between EGFR Gene Amplification and the Prognosis in Non-small Cell Lung Cancer: A meta-analysis
by: Jie WANG, et al.
Published: (2009-12-01)

Analysis of the Efficacy of Immunotherapy on the Posterior Lines  of Advanced EGFR Mutant Patients with Non-small cell Lung Cancer
by: Li MA, et al.
Published: (2021-05-01)

Analysis of Mutations in Epidermal Growth Factor Receptor Gene in Korean Patients with Non-small Cell Lung Cancer: Summary of a Nationwide Survey
by: Sang Hwa Lee, et al.
Published: (2015-11-01)

Final Overall Survival Results from the FLAURA Trial: a Phase III Study on Osimertinib in EGFRMutated Advanced Non-small Cell Lung Cancer
by: Yue WANG, et al.
Published: (2020-06-01)

Effect and Mechanism of Gefitinib Inhibition on Non-small Cell Lung Cancer  Radiosensitivity of HCC827 and H358 Cell Lines
by: Ziye GAO, et al.
Published: (2012-06-01)

Prognostic Analysis of Patients with Advanced Non-small Cell Lung Cancer  in Different Genotypes
by: Ping LIU, et al.
Published: (2017-11-01)

Molecular Mechanism of Erlotinib Resistance in Epidermal Growth Factor Receptor  Mutant Non-small cell Lung Cancer Cell Line H1650
by: Ruili HAN, et al.
Published: (2012-12-01)

Factors that Predict Clinical Benefit of EGFR TKI Therapy in Patients with EGFR Wild-Type Lung Adenocarcinoma
by: Seo Yun Kim, M.D., et al.
Published: (2019-01-01)

Clinical Study of Erlotinib in the Treatment of Patients with Advanced Stage Non-small Cell Lung Cancer
by: Renhua GUO, et al.
Published: (2009-12-01)

Studies and Progress of EGFR exon 20 Insertion Mutation in Non-small Cell Lung Cancer
by: Wensheng ZHOU, et al.
Published: (2020-02-01)

Effects of Monoclonal Antibody Cetuximab on Proliferation of Non-small Cell Lung Cancer Cell lines
by: Zhen CHEN, et al.
Published: (2010-08-01)

Comparison of EGFR and KRAS Status between Primary Non-small Cell Lung Cancer and Corresponding Metastases: A Systematic Review and meta-analysis
by: Chengbo HAN, et al.
Published: (2010-09-01)

Recent Advances in Association of Estrogen and Non-small Cell Lung Cancer
by: Xiaosheng DING, et al.
Published: (2017-06-01)

Detection and Its Clinical Significance of EGFR Gene Mutation and Gene Amplification in 187 Patients with Non-small Cell Lung Cancer
by: Qinghua ZHOU, et al.
Published: (2009-12-01)

Discordance of Epidermal Growth Factor Receptor Mutations between Primary  and Corresponding Metastatic Tumors in Non-small Cell Lung Cancer
by: Qin FANG, et al.
Published: (2011-06-01)

Detection of EGFR and COX-2 Expression by Immunohistochemical Method on a Tissue Microarray Section in Lung Cancer and Biological Significance
by: Xinyun WANG, et al.
Published: (2010-02-01)

Advances in Double Mutations of EGFR and ALK Gene in Non-small Cell Lung Cancer
by: Xin WANG, et al.
Published: (2018-09-01)

A Review of EGFR-TKIs Therapy of Non-small Cell Lung Cancer with Uncommon EGFR Mutations
by: Wenxing DU, et al.
Published: (2019-09-01)

Advances in Antiangiogenic Treatment of Advanced Non-squamous Non-small Cell Lung Cancer in 2017 ASCO and WCLC
by: Lianfang NI, et al.
Published: (2018-05-01)

Effect of rs2293347 Polymorphism in EGFR on the Clinical Efficacy of Gefitinib  in Patients with Non-small Cell Lung Cancer
by: Fei MA, et al.
Published: (2011-08-01)

Clinical Research of EGFR and KRAS Mutation in Fine Needle Aspiration Cytology Specimens of Non-small Cell Lung Carcinoma
by: Zhihui ZHANG, et al.
Published: (2015-04-01)

Detection and Evaluation of EGFR Mutation Status in Serum of Patients with Advanced Non-small Cell Lung Cancer Treated with EGFR-TKIs
by: Ling MA, et al.
Published: (2013-06-01)

Advances in the Transformation to Small Cell Lung Cancer from Non-small Cell Lung Cancer Following Acquired Drug-resistance to EGFR Tyrosine Kinase Inhibitors
by: Wenqiu ZHANG, et al.
Published: (2017-10-01)

Detection and Analysis of EGFR and KRAS Mutation with Lung Adenocarcinoma
by: Hui ZHANG, et al.
Published: (2015-11-01)

Transformation to Small Cell Lung Cancer of Pulmonary Adenocarcinoma: Clinicopathologic Analysis of Six Cases
by: Soomin Ahn, et al.
Published: (2016-07-01)

Analysis of the Relationship Between the Quality of Small Biopsy Specimens of  Non-small Cell Lung Cancer and the Mutation Rate of EGFR Gene
by: Yuqin LI, et al.
Published: (2021-05-01)

The Relationship between EGFR Mutations and Response and Prognosis of Tyrosine Kinase Inhibitors in Advanced Non-small-cell Lung Cancer
by: Xuebing LI, et al.
Published: (2008-04-01)

EGFR-dependent Impact of Indol-3-Carbinol on Radiosensitivity  of Lung Cancer Cells
by: Xiao XIAO, et al.
Published: (2012-07-01)